首页> 外文期刊>Acta biomaterialia >Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy
【24h】

Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy

机译:用红细胞膜官能化的氧自富富纳米颗粒,用于长循环和增强的光疗法

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In recent years, indocyanine green (ICG) encapsulated in different kinds of nano-carriers have been developed to overcome its short lifetime in vivo and non-selectivity in cancer cells. However, these nanoparticles are still easily recognized and captured by the reticuloendothelial system (RES) and the low singlet oxygen quantum (0.08) of ICG inevitably leads to a limited efficacy of phototherapy. To overcome these limitations, a novel oxygen self-enriched biomimetic red blood cell (RBC) was developed by cloaking albumin nanoparticles which contained ICG and perfluorocarbon (PFC) with RBC membranes. Due to the high oxygen capacity of PFC, the oxygen self-enriched nanoparticles can enhance photodynamic therapy (PDT) by generating more singlet oxygen (O-1(2)). After successfully coated RBC membranes onto nanoparticles, the novel oxygen self-enriched biomimetic RBCs remained the characteristics of photothermal therapy (PTT) and enhanced PDT in vitro. Importantly, it can effectively reduce immune clearance in macrophage cells (RAW264.7) and significantly prolong blood circulation time, achieving high accumulation in tumor. In addition, the tumor growth was effectively inhibited after intravenous injection to tumor-bearing mice. Altogether, this oxygen self-enriched RBCs with long circulation time and high oxygen capacity as natural RBCs provide a new strategy to design biomimetic nano-system for clinical cancer phototherapy treatment.
机译:近年来,已经开发出在不同种类的纳米载体中包封的吲哚菁绿(ICG)以克服其在癌细胞中的体内和非选择性的短生活动。然而,这些纳米颗粒仍然容易被视网膜内的系统(RES)和ICG的低单次氧量子(0.08)不可避免地导致光疗的有限疗效。为了克服这些限制,通过用RBC膜含有ICG和全氟碳(PFC)的粘附白蛋白纳米颗粒开发了一种新的氧自富集的仿生红细胞(RBC)。由于PFC的高氧容量,氧自富集的纳米颗粒可以通过产生更多单线次氧(O-1(2))来增强光动力治疗(PDT)。在将RBC膜成功涂覆到纳米颗粒上之后,新型氧自富集的仿生RBC仍然是光热疗法(PTT)和体外增强PDT的特征。重要的是,它可以有效降低巨噬细胞(Raw264.7)的免疫清除,并显着延长血液循环时间,实现肿瘤的高积累。此外,在静脉注射到肿瘤的小鼠后有效抑制肿瘤生长。总共,这种具有长循环时间和高氧气能力的氧气自富集的RBC作为天然RBCS提供了一种设计临床癌症光疗法的仿生纳米系统的新策略。

著录项

  • 来源
    《Acta biomaterialia》 |2017年第2017期|共14页
  • 作者单位

    Nanjing Univ Sch Med State Key Lab Pharmaceut Biotechnol Nanjing 210093 Jiangsu Peoples R China;

    Nanjing Univ Sch Med State Key Lab Pharmaceut Biotechnol Nanjing 210093 Jiangsu Peoples R China;

    Nanjing Univ Sch Med State Key Lab Pharmaceut Biotechnol Nanjing 210093 Jiangsu Peoples R China;

    Nanjing Univ Sch Med State Key Lab Pharmaceut Biotechnol Nanjing 210093 Jiangsu Peoples R China;

    Nanjing Univ Sch Med State Key Lab Pharmaceut Biotechnol Nanjing 210093 Jiangsu Peoples R China;

    Nanjing Univ Sch Med State Key Lab Pharmaceut Biotechnol Nanjing 210093 Jiangsu Peoples R China;

    Nanjing Univ Sch Med State Key Lab Pharmaceut Biotechnol Nanjing 210093 Jiangsu Peoples R China;

    Nanjing Univ Sch Med State Key Lab Pharmaceut Biotechnol Nanjing 210093 Jiangsu Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 普通生物学;
  • 关键词

    Biomimetic red blood cell; Indocyanine green; Perfluorocarbon; Red blood cell membranes; Long circulation; Enhanced phototherapy;

    机译:仿生红细胞;吲哚菁绿;全氟化碳;红细胞膜;长循环;增强光疗法;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号